PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27221705-4	2016	We found that 4NQO and arecoline upregulated miR-211 expression in OSCC cells.	4-Nitroquinoline-1-oxide	14-18	microRNA 211	Homo sapiens	45-52	
27221705-4	2016	We found that 4NQO and arecoline upregulated miR-211 expression in OSCC cells.	Arecoline	23-32	microRNA 211	Homo sapiens	45-52	
27221705-7	2016	FAM213A silencing in OSCC cells diminished oncogenic activity, reduced the ALDH1-positive cell population, and increased reactive oxygen species.	Reactive Oxygen Species	121-144	peroxiredoxin like 2A	Homo sapiens	0-7	
27221705-10	2016	Furthermore, 4NQO treatment downregulated TCF12 and upregulated FAM213A by modulating miR-211 both in vitro and in vivo Overall, our findings develop a mouse model that recapitulates the molecular and histopathologic alterations of human OSCC pathogenesis and highlight a new miRNA-mediated oncogenic mechanism.	4-Nitroquinoline-1-oxide	13-17	transcription factor 12	Mus musculus	42-47	
27221705-10	2016	Furthermore, 4NQO treatment downregulated TCF12 and upregulated FAM213A by modulating miR-211 both in vitro and in vivo Overall, our findings develop a mouse model that recapitulates the molecular and histopathologic alterations of human OSCC pathogenesis and highlight a new miRNA-mediated oncogenic mechanism.	4-Nitroquinoline-1-oxide	13-17	peroxiredoxin like 2A	Mus musculus	64-71	
27221705-10	2016	Furthermore, 4NQO treatment downregulated TCF12 and upregulated FAM213A by modulating miR-211 both in vitro and in vivo Overall, our findings develop a mouse model that recapitulates the molecular and histopathologic alterations of human OSCC pathogenesis and highlight a new miRNA-mediated oncogenic mechanism.	4-Nitroquinoline-1-oxide	13-17	microRNA 211	Mus musculus	86-93